Influence of health resort treatment on the level of systemic inflammation in patients after new coronavirus infection

Background. Low-grade inflammation is currently one of the main risk factors for the development of adverse events in the cardiovascular system, including death from cardiovascular diseases or their complications that cause mortality in the postCOVID period.

The aim of the study. To assess the impact of health resort treatment in the conditions of the Southern Coast of Crimea on clinical and functional parameters, as well as on the level of systemic inflammation in patients after a new coronavirus infection.

Materials and methods. The study included 67 patients (54.9 ± 9.05 years) in the post-COVID period who underwent health resort treatment at the I.M. Sechenov Academic Research Institute of Physical Treatment Methods, Medical Climatology and Rehabilitation. Methods of health resort treatment included climatic treatment on the Southern Coast of Crimea, therapeutic breathing exercises, terrainkur, and various methods of respiratory therapy. In all patients, the study of the C-reactive protein (CRP) in peripheral blood upon admission and at discharge was carried out.

Results. Despite a statistically significant improvement in most clinical and functional parameters, the level of CRP and the number of leukocytes and their subpopulations in peripheral blood in patients who underwent health resort treatment did not differ significantly (p > 0.05) from the baseline values obtained upon admission at the I.M. Sechenov Academic Research Institute of Physical Treatment Methods, Medical Climatology and Rehabilitation. The CRP index upon admission and at discharge corresponded to the lower limit of the interval specific for low-grade inflammation (from 3 to 10 mg/l).

Conclusion. Our results indicate the lack of effectiveness of the presented plan of health resort treatment in the correction of low-intensity inflammation, as well as the necessity for deeper scientific research in the direction of studying the mechanisms of low-grade inflammation development and the methods of its management.

1. COVID-19 coronavirus pandemic worldometer. URL: https://www.worldometers.info/coronavirus/ [date of access: 23.08.2022].

2. Dotan A, Shoenfeld Y. Post-COVID syndrome: The aftershock of SARS-CoV-2. Int J Infect Dis. 2022; 114: 233-235. doi: 10.1016/j.ijid.2021.11.020

3. Rifai N, Ridker PM. Population distributions of C-reactive protein in apparently healthy men and women in the United States: Implication for clinical interpretation. Clin Chem. 2003; 49(4): 666-669. doi: 10.1373/49.4.666

4. Imhof A, Fröhlich M, Loewel H, Helbecque N, Woodward M, Amouyel P. Distributions of C-reactive protein measured by highsensitivity assays in apparently healthy men and women from different populations in Europe. Clin Chem. 2003; 49(4): 669-672. doi: 10.1373/49.4.669

5. Lüscher TF. Cardio-oncology: Low-grade inflammation as a common pathway of cancer and cardiovascular disease. Eur Heart J. 2019; 40(48): 3871-3874. doi: 10.1093/eurheartj/ehz928

6. Silva Andrade B, Siqueira S, de Assis Soares WR, de Souza Rangel F, Santos NO, Dos Santos Freitas A, et al. Long-COVID and post-COVID health complications: An up-to-date review on clinical conditions and their possible molecular mechanisms. Viruses. 2021; 13(4): 700. doi: 10.3390/v13040700

7. Franceschi C, Garagnani P, Parini P, Giuliani C, Santoro A. Inflammaging: A new immune-metabolic viewpoint for age-related diseases. Nat Rev Endocrinol. 2018; 14(10): 576-590. doi: 10.1038/s41574-018-0059-4

8. Ortega-Gómez A, Perretti M, Soehnlein O. Resolution of inflammation: an integrated view. EMBO Mol Med. 2013; 5(5): 661-674. doi: 10.1002/emmm.201202382

9. Calder PC, Ahluwalia N, Albers R, Bosco N, BourdetSicard R, Haller D, et al. A consideration of biomarkers to be used for evaluation of inflammation in human nutritional studies. Br J Nutr. 2013; 109(Suppl 1): S1-S34. doi: 10.1017/S0007114512005119

10. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol. 2008; 8(5): 349-361. doi: 10.1038/nri2294

11. Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006; 444(7121): 860-867. doi: 10.1038/nature05485

12. Hallenbeck JM, Hansson GK, Becker KJ. Immunology of ischemic vascular disease: Plaque to attack. Trends Immunol. 2005; 26(10): 550-556. doi: 10.1016/j.it.2005.08.007

13. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352(16): 1685-1695. doi: 10.1056/NEJMra043430

14. Har ford K A, R eynolds CM, M cGillicuddy FC, Roche HM. Fats, inflammation and insulin resistance: Insights to the role of macrophage and T-cell accumulation in adipose tissue. Proc Nutr Soc. 2011; 70(4): 408-417. doi: 10.1017/S0029665111000565

15. Collaboration IRGCERF, Sarwar N, Butterworth AS, Freitag DF, Gregson J, Willeit P, et al. Interleukin-6 receptor pathways in coronary heart disease: A collaborative meta-analysis of 82 studies. Lancet. 2012; 379(9822): 1205-1213. doi: 10.1016/S0140-6736(11)61931-4

16. Biagi E, Franceschi C, Rampelli S, Severgnini M, Ostan R, Turroni S, et al. Gut microbiota and extreme longevity. Curr Biol. 2016; 26(11): 1480-1485. doi: 10.1016/j.cub.2016.04.016

17. Wang H, Peng G, Bai J, He B, Huang K, Hu X, et al. Cytomegalovirus infection and relative risk of cardiovascular disease (ischemic heart disease, stroke, and cardiovascular death): A meta-analysis of prospective studies up to 2016. J Am Heart Assoc. 2017; 6(7): e005025. doi: 10.1161/JAHA.116.005025

18. Karczewski J, Śledzińska E, Baturo A, Jończyk I, Maleszko A, Samborski P, et al. Obesity and inflammation. Eur Cytokine Netw. 2018; 29(3): 83-94. doi: 10.1684/ecn.2018.0415

19. Suárez-Reyes A, Villegas-Valverde CA. Implications of lowgrade inflammation in SARS-CoV-2 immunopathology. MEDICC Rev. 2021; 23(2): 42. doi: 10.37757/MR2021.V23.N2.4

20. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol (1985). 2005; 98(4): 1154-1162. doi: 10.1152/japplphysiol.00164.2004

21. Gleeson M, Bishop NC, Stensel DJ, Lindley MR, Mastana SS, Nimmo MA. The anti-inflammatory effects of exercise: Mechanisms and implications for the prevention and treatment of disease. Nat Rev Immunol. 2011; 11(9): 607-615. doi: 10.1038/nri3041. PMID: 21818123